Geriatric Communication Skills Training Program for Oncology Clinicians

NCT ID: NCT03530969

Last Updated: 2024-02-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

88 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-07

Study Completion Date

2024-02-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to learn more about the effects of a training program designed to help doctors communicate better with older patients and their caregivers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

GI Cancer Lymphoma GU Cancer Bone Marrow Transplant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GI/GU/Lymphoma Oncologists

Doctors specializing in treating gastrointestinal cancer (cancer of the stomach, pancreas, colon, etc.), genitourinary cancer (cancer of the genitals and urinary tract), and lymphoma (cancer affecting the blood and lymph nodes)

Group Type EXPERIMENTAL

Self-Efficacy Assessment

Intervention Type BEHAVIORAL

Health Care Professional's self-efficacy will be assessed by 12 ratings of self-reported confidence from (1) "strongly disagree" to (5) "strongly agree" in module-specific topics both before and after the training.

UCLA Geriatrics Attitudes Scale

Intervention Type BEHAVIORAL

The UCLA Geriatrics Attitudes Scale is a 14-item scale developed to assess health care providers' attitudes toward older persons and caring for older patients.

Course Evaluations

Intervention Type BEHAVIORAL

The evaluation surveys for each of the three modules will contain fifteen statements assessing post-training attitudes regarding the skills learned and application of skills in oncology clinical practice, measured on a 5-point Likert scale.

Participants with GI/GU/Lymphoma Cancer

Patients of the physicians in group 1

Group Type ACTIVE_COMPARATOR

The Consultation and Relational Empathy (CARE) questionnaire

Intervention Type BEHAVIORAL

The Consultation and Relational Empathy (CARE) questionnaire is a 10-item self-report scale that measures a patient's satisfaction with how empathic their health care providers (HCP) was within a specific consultation.

Consumer Assessment of Health Care Providers and Systems Program (CAHPS)

Intervention Type BEHAVIORAL

Patients" perceptions of the quality of their interactions with their clinicians will be rated with 6 items from the Consumer Assessment of Health Care Providers and Systems Program (CAHPS)

Patient activation measure (PAM) scale

Intervention Type BEHAVIORAL

The PAM scale contains 22 items that assess patient engagement in their care process.

Caregivers of Participants with GI/GU/Lymphoma Cancer

Family members or caregivers of the patients in group 2

Group Type ACTIVE_COMPARATOR

The Consultation and Relational Empathy (CARE) questionnaire

Intervention Type BEHAVIORAL

The Consultation and Relational Empathy (CARE) questionnaire is a 10-item self-report scale that measures a patient's satisfaction with how empathic their health care providers (HCP) was within a specific consultation.

Consumer Assessment of Health Care Providers and Systems Program (CAHPS)

Intervention Type BEHAVIORAL

Patients" perceptions of the quality of their interactions with their clinicians will be rated with 6 items from the Consumer Assessment of Health Care Providers and Systems Program (CAHPS)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Self-Efficacy Assessment

Health Care Professional's self-efficacy will be assessed by 12 ratings of self-reported confidence from (1) "strongly disagree" to (5) "strongly agree" in module-specific topics both before and after the training.

Intervention Type BEHAVIORAL

UCLA Geriatrics Attitudes Scale

The UCLA Geriatrics Attitudes Scale is a 14-item scale developed to assess health care providers' attitudes toward older persons and caring for older patients.

Intervention Type BEHAVIORAL

Course Evaluations

The evaluation surveys for each of the three modules will contain fifteen statements assessing post-training attitudes regarding the skills learned and application of skills in oncology clinical practice, measured on a 5-point Likert scale.

Intervention Type BEHAVIORAL

The Consultation and Relational Empathy (CARE) questionnaire

The Consultation and Relational Empathy (CARE) questionnaire is a 10-item self-report scale that measures a patient's satisfaction with how empathic their health care providers (HCP) was within a specific consultation.

Intervention Type BEHAVIORAL

Consumer Assessment of Health Care Providers and Systems Program (CAHPS)

Patients" perceptions of the quality of their interactions with their clinicians will be rated with 6 items from the Consumer Assessment of Health Care Providers and Systems Program (CAHPS)

Intervention Type BEHAVIORAL

Patient activation measure (PAM) scale

The PAM scale contains 22 items that assess patient engagement in their care process.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Perceived Ageism Perceived Empathy Satisfaction with communication Patient Activation.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Clinician Eligibility

* MSK medical oncology Health Care Professionals (HCP) - specifically identified as Attendings, fellows, or Advance Practice Professional (APP) - either a Nurse Practitioner (NP) or Physician Assistant (PA) from GI, GU Oncology, Lymphoma, Bone Marrow Transplant or Geriatrics Service (five services with a large number of geriatric patients)
* Willingness to be audio-recorded as per self-report
* Clinician has individual clinic consultations with patients in the target population: 65 years of age and over, English speaking, and patients who have had a new visit within the last 6 months.

Patient Eligibility

* MSK patients 65 years of age and over as per EMR
* English speaking as per EMR
* Being seen by one of the consented HCPs as per the HCP and/or electronic medical record (EMR)
* Willingness to be audio-recorded as per self-report
* Patient had their first visit with the clinician within the last 6 months

Caregiver Eligibility

* English speaking as per EMR
* Accompanying an MSK patient being seen by one of the consented HCPs as per the HCP and/or EMR

Exclusion Criteria

* N/A
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Memorial Sloan Kettering Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Smita Banerjee, PhD

Role: PRINCIPAL_INVESTIGATOR

Memorial Sloan Kettering Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mskcc.org

Memorial Sloan Kettering Cancer Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18-183

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.